| Literature DB >> 26122630 |
Ertugrul Kiykim1, Kenan Barut2, Mehmet Serif Cansever3, Cigdem Aktuglu Zeybek4, Tanyel Zubarioglu4, Ahmet Aydin4, Ozgur Kasapcopur2.
Abstract
Mucopolysaccharidosis is a group of lysosomal disorders of a deficiency of specific enzyme required for glycosaminoglycan degradation. Mucopolysaccharidosis type IX is the rarest form of mucopolysaccharidosis. To date, only four patients have been reported. The first reported patient had mild short stature and periarticular soft tissue masses; the other reported patients are clinically indistinguishable from juvenile idiopathic arthritis. In the present study, we screened mucopolysaccharidosis type IX among patients with juvenile idiopathic arthritis with hyaluronidase enzyme assay. One hundred and eight patients with JIA and 50 healthy age-matched control subjects were enrolled in the study. Among all patients, none had deficient hyaluronidase activity. Though serum Hyal-1 activity was significantly increased in JIA patients, compared with control subjects (p < 0.000), no correlation was found between CRP, ESR, and Hyal-1 activity (p = 0.187). In conclusion, the data reported in our study indicates that systemic metabolic investigation for hyaluronidase activity is not recommended in all patients with JIA.Entities:
Keywords: Hyaluronidase deficiency; Juvenile idiopathic arthritis; Mucopolysaccharidosis type IX
Year: 2015 PMID: 26122630 PMCID: PMC5059191 DOI: 10.1007/8904_2015_467
Source DB: PubMed Journal: JIMD Rep ISSN: 2192-8304